Innate Pharma
Tracked across 2 events · 15 articles · First seen Apr 02, 2026 · Last active Apr 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Regulatory
Innate Pharma filed its 2025 Universal Registration Document with the France===Autorité des marchés financiers (AMF) and its Form 20-F annual report with the United States===United States Securities and Exchange Commission (SEC). This is a routine regulatory compliance action.
Apr 02, 2026 · 8 articles
Business
Innate Pharma will present its oncology pipeline, platforms, and strategies for innovation at the AACR Oncology Industry Partnering Event, providing a valuable opportunity to share progress on key assets like IPH4502. This presentation could attract investor interest and potentially accelerate the development of its therapies.
Apr 08, 2026 · 7 articles
90
Innate Pharma selected to present at industry partnering event American Association for Cancer ResearchInnate Pharma to Present...
Yannis Morel
Chief Operating Officer
↔
Innate Pharma
Yannis Morel holds the position of Chief Operating Officer at Innate Pharma.
NEWSDESK
Track Innate Pharma live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard